Published in Acta Gastroenterol Belg on March 28, 2000
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut (2001) 4.23
Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? Aliment Pharmacol Ther (2012) 2.74
Genetic analyses of chromosome 12 loci in Crohn's disease. Gut (2000) 2.30
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol (1998) 2.20
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Aliment Pharmacol Ther (2004) 1.87
A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol (1997) 1.85
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther (2004) 1.62
Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia (1997) 1.50
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun (2007) 1.50
A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism. Scand J Gastroenterol (2002) 1.38
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol (2000) 1.30
Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab (1999) 1.25
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol (2000) 1.06
Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Am J Gastroenterol (2002) 1.03
Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy (1995) 0.98
Profile of soluble cytokine receptors in Crohn's disease. Gut (2005) 0.97
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol (1996) 0.96
CARD4/NOD1 is not involved in inflammatory bowel disease. Gut (2003) 0.94
Acute pancreatitis attributed to the use of interferon alfa-2b. Gastroenterology (2000) 0.92
Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul Pept (1998) 0.91
Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. J Clin Endocrinol Metab (1993) 0.89
Anti-tumor necrosis factor nonresponders in Crohn's disease: therapeutic strategies. Dig Dis (2009) 0.89
Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Aliment Pharmacol Ther (1995) 0.88
Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology (1989) 0.88
Clinical pattern of corticosteroid dependent Crohn's disease. Eur J Gastroenterol Hepatol (1998) 0.88
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepatology (1995) 0.86
Clustering of Crohn's disease within affected sibships. Eur J Hum Genet (2003) 0.85
Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol (2004) 0.85
Development of adenocarcinoma in chronic fistula in Crohn's disease. Acta Gastroenterol Belg (2005) 0.84
[Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine]. Rev Med Liege (1998) 0.83
Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003. Acta Gastroenterol Belg (2006) 0.83
Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy (1999) 0.83
Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission. Int J Colorectal Dis (2000) 0.82
Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures. Dig Dis Sci (1999) 0.81
Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids. J Crohns Colitis (2011) 0.81
Incidence of inflammatory bowel disease in the area of Liège: a 3 years prospective study (1993-1996). Acta Gastroenterol Belg (1999) 0.81
Effect of ranitidine on cobalamin absorption. Dig Dis Sci (1983) 0.80
Altered expression of type I insulin-like growth factor receptor in Crohn's disease. Clin Exp Immunol (2005) 0.80
[Acute colitis in Wegener's disease: a case report]. Rev Med Liege (2006) 0.80
Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease. Eur J Hum Genet (2001) 0.79
Are we giving biologics too much time? When should we stop treatment? World J Gastroenterol (2008) 0.79
Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine. Aliment Pharmacol Ther (2003) 0.78
Familial Crohn's disease: a study of 18 families. Acta Gastroenterol Belg (1997) 0.78
Medical treatment of chronic anal fissure. where do we stand on reversible chemical sphincterotomy? Acta Gastroenterol Belg (2004) 0.78
Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience. Acta Chir Belg (2006) 0.78
Barrett's esophagus and its relationship to cancer. J Belge Radiol (1991) 0.78
Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group. Acta Gastroenterol Belg (1998) 0.78
Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Dig Dis Sci (1995) 0.78
Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther (2002) 0.78
[2 fatal cases of yellow fever seen in France and contracted in Senegal (epidemiological and clinical aspects)]. Bull Soc Pathol Exot Filiales (1980) 0.78
Hepatitis C virus transmission following invasive medical procedures. J Intern Med (1999) 0.78
[Non-specific chronic ulcerous jejuno-ileitis. Presentation of a new case]. Gastroenterol Clin Biol (1977) 0.77
Treatment of acute diarrhoea: update of guidelines based on a critical interuniversity assessment of medications and current practices. Acta Gastroenterol Belg (2003) 0.77
Genetics of Crohn's disease behaviour. Acta Gastroenterol Belg (2001) 0.77
Experimental models of inflammatory bowel disease. Acta Gastroenterol Belg (1995) 0.77
Effect of folate deficiency on vitamin B12 absorption. Ann Nutr Metab (1982) 0.77
[Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory diseases of the digestive tract]. Acta Gastroenterol Belg (1994) 0.77
[Insulinoma: diagnostic elements. 13 cases]. Presse Med (1985) 0.76
[Pseudo-alcoholic hepatitis and cirrhosis caused by amiodarone (Cordarone)]. Rev Med Liege (1998) 0.76
A patient who survived total colonic ulcerative colitis surinfected by cytomegalovirus complicated by toxic megacolon and disseminated intravascular coagulation. Acta Gastroenterol Belg (2005) 0.76
Incidence of inflammatory bowel disease in the province of Liège (Belgium). La Société de Gastroentérologie Liègeoise. Acta Gastroenterol Belg (1996) 0.76
Effect of chronic ranitidine treatment on secretion of intrinsic factor. Br Med J (Clin Res Ed) (1982) 0.75
[Genomics of inflammatory bowel diseases: basis for a new molecular classification and new therapeutic strategies of these diseases]. Rev Med Liege (2009) 0.75
A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs. Ann Rheum Dis (2004) 0.75
Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease. Scand J Gastroenterol (2001) 0.75
Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply. Aliment Pharmacol Ther (2013) 0.75
[Nodular regenerative hyperplasia of the liver with portal hypertension associated with Felty's syndrome. Report of a case (author's transl)]. Gastroenterol Clin Biol (1978) 0.75
[Anatomo-clinical study of a case of regenerative nodular hyperplasia of the liver with Felty's syndrome and portal hypertension]. Ann Anat Pathol (Paris) (1979) 0.75
[Serum lysozyme in ulcerative colitis and Crohn's disease]. Arch Fr Mal App Dig (1976) 0.75
[Small cell bronchial cancer, Schwartz-Bartter syndrome and hyperthyrocalcitonemia. Apropos of 2 cases]. Nouv Presse Med (1974) 0.75
[Biologic therapies in chronic inflammatory bowel diseases]. Rev Med Liege (2009) 0.75
[Diuretic-induced acute hyponatremia in a hypertensive patient without edemas (author's transl)]. Schweiz Rundsch Med Prax (1978) 0.75
[Genetics and environment in chronic inflammatory bowel diseases]. Rev Med Liege (2012) 0.75
The deoxyuridine suppression test in macrocytosis of chronic alcoholism. Am J Clin Nutr (1978) 0.75
[Comparison of the efficacy of laparoscopy and puncture biopsy with a Menghini needle in the diagnosis of cirrhosis of the liver]. Sem Hop (1976) 0.75
[Hypocalcemia and intestinal bypass for obesity (author's transl)]. Nouv Presse Med (1979) 0.75
[Ménétrier's disease with protein and calcium loss (author's transl)]. Arch Fr Mal App Dig (1977) 0.75
"Folate-losing gastropathy" and intestinal folate absorption in patients with Ménétrier's disease (giant hypertrophic gastritis). Am J Dig Dis (1978) 0.75
Depth of remission in Crohn's disease patients seen in a referral centre : associated factors and impact on disease outcome. Acta Gastroenterol Belg (2014) 0.75
[Prostate cancer and disseminated intravascular blood coagulation]. Sem Hop (1973) 0.75
[Fifteen years of use of anti-TNF antibodies in moderate to severe Crohn's disease: how to make the best of this experience]. Rev Med Liege (2012) 0.75
[Monoclonal antibodies therapies for colorectal cancer: cétuximab, panitumumab and bevacizumab]. Rev Med Liege (2009) 0.75
[Adenocarcinoma of the small intestines complicating coeliac disease in an adult: case report]. Rev Med Liege (2009) 0.75
[Hypercalcemia in cancer of the esophagus]. Nouv Presse Med (1977) 0.75
Book Reviews. Acta Clin Belg (1989) 0.75
[Macrocytosis in chronic alcoholism: a disturbance of DNA synthesis related to folate deficiency? (author's transl)]. Gastroenterol Clin Biol (1978) 0.75
Should patients under long-term anti-TNF therapies be followed for tuberculosis contamination? Inflamm Bowel Dis (2010) 0.75
Book Review. Acta Clin Belg (1990) 0.75
[Heat stroke with anuria, muscular disorders and early hypercalcemia]. Nouv Presse Med (1977) 0.75
Persisting signs of disease activity at Magnetic Resonance Enterocolonography predict clinical relapse and disease progression in quiescent Crohn's disease. Acta Gastroenterol Belg (2015) 0.75
Letter: Hyperthyrocalcitoninaemia, Schwartz-Bartter syndrome, and oat-cell carcinoma. Lancet (1974) 0.75
[Sphincterotomy and ablation of choledochal calculi by endoscopy. Apropos of 14 cases]. Ann Med Interne (Paris) (1977) 0.75
Letter: Serum lysozyme in inflammatory bowel disease. Gastroenterology (1976) 0.75
[FROM EVIDENCE-BASED MEDICINE TO PERSONALIZED MEDICINE IN CROHN'S DISEASE]. Rev Med Liege (2015) 0.75
Hepatitis C of genotype 2: the role of medical invasive exams. Acta Gastroenterol Belg (2011) 0.75
[Hypercalcemia in patients with primary carcinoma of the liver without bone metastases (author's transl)]. Arch Fr Mal App Dig (1975) 0.75